US · Healthcare

TerrAscend Corp. (TSNDF)

Drug Manufacturers - Specialty & Generic

TerrAscend Corp. (TSNDF) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-25, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for TSNDF

P/E ratio

18.00

TerrAscend Corp. (TSNDF) — FAQ

What is TSNDF's P/E ratio?

The price-to-earnings (P/E) ratio for TerrAscend Corp. (TSNDF) is 18.00 (data as of 2026-03-25).

Does TerrAscend Corp. pay a dividend?

Dividend yield is not available in the current snapshot for TerrAscend Corp. (TSNDF). Check the MyAverix Finance app for the latest dividend data.

What sector is TerrAscend Corp. in?

TerrAscend Corp. (TSNDF) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is TSNDF listed on?

TSNDF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)